U.S. market Closed. Opens in 14 hours 1 minute

SLRN | Acelyrin, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-31
RevenueN/AN/AN/A
Cost of Revenue115.00KN/AN/A
Gross Profit-115.00KN/AN/A
Operating Expenses422.06M254.68M41.79M
Selling, General & Admin66.18M24.05M3.56M
Research & Development355.89M230.63M38.23M
Other Operating ExpensesN/A-132.00K-45.00K
Operating Income-422.06M-254.68M-41.79M
Other Expenses / Income40.42M4.41M-45.00K
Before Tax Income-381.64M-250.46M-41.84M
Income Tax ExpensesN/A-4.17M-41.79K
Net Income-381.64M-250.46M-41.84M
Interest ExpensesN/AN/AN/A
Basic Shares Outstanding70.25M20.44M20.44M
Diluted Shares Outstanding70.25M20.44M20.44M
EBITDA-381.53M-64.77M-41.84M
EBITDA Margin0.00%0.00%0.00%
EBIT-381.64M-254.63M-41.88M
EBIT Margin0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙